Early IHC analyses in postmortem brain tissue identified complement components and activation products, predominantly from the classical and terminal pathways, localized to reactive astrocytes and neurons containing Pick bodies in cases of PiD [109], and on neurofibrillary tangles in cases of AD with tau pathology [110] and Guam Parkinsonism-dementia [111]. This evidence concerns the gene MAPT and Alzheimer disease.